
AstraZeneca and GlaxoSmithKline are key players in the COPD market.
Top news of the day from across the health care landscape.
Compound in olive oil inhibits disease activity of certain proteins.
The software helps track Interferon beta-1b injections among MS patients.
Sequence of drug administration is crucial to the success of combination treatments for cancer using cannabinoids.
Medications that suppress viral loads aid HIV-infected men who want children.
The drug offers a new therapeutic option to help manage RA.
HCV drug greatly reduced the rates of liver transplants and mortality in patients with advanced stages of cirrhosis.
The guide seeks to provide health care professionals with reference information on the science and regulation underpinning biosimilar use.
Top news of the day from across the health care landscape.
The FDA recommends a 200-mg dose of pembrolizumab every 3 weeks, but researchers disagree.
Another state passes legislation to increase uptake of biosimilars.
HIV/AIDS is the number 1 killer among women of reproductive age.
Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.
Powder formulation of HIV drug receives FDA approval.
Filgotinib may offer new option for patients with rheumatoid arthritis who have an inadequate response to methotrexate.
Top news of the day from across the health care landscape.
Use of natural, herbal, vitamin, and traditional cures available in grocery stores, gas stations, drugstores, health food stores, and from the Internet continues to grow.
Symposium on PCSK9 inhibitors in treatment of type 1 diabetes highlighted at 77th Scientific Sessions of the ADA.
Men who have sex with men had the highest number of HIV diagnoses.
The drug is indicated as a combination treatment of HIV and for pre-exposure prophylaxis.
Method could help provide more personalized treatments for patients with skin cancer.
Tests provide little to no benefit and can increase a breast cancer patient’s financial burden.
Top articles of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
There are few shortcuts that address the large number of medications and different treatment regimens that are needed to treat patients with HIV.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The National Society of Specialty Pharmacy pushes for the creation of meaningful quality measures to improve direct and indirect remuneration fee reporting.
Both 15-mg and 30-mg doses of upadacitinib achieved desired endpoints in the treatment of rheumatoid arthritis.
Treatment de-escalation would reduce adverse events, treatment costs, and the need for virological monitoring.